References
- Albanes D, Weinstein SJ, Wright ME, et al (2009). Serum insulin, glucose, indices of insulin resistance, and risk of prostate cancer. J Natl Cancer Inst, 101, 1272-9. https://doi.org/10.1093/jnci/djp260
- Asafudullah SM, Salam MA, Badruddoza SM (2011). Evaluation of diagnostic accuracy of different biomarkers for prostate cancer. Pak J Med Sci, 27, 48-51.
- Belbase NP, Agrawal CS, Pokharel PK, et al (2013). Prostate cancer screening in a healthy population cohort in eastern Nepal: an explanatory trial study. Asian Pac J Cancer Prev, 14, 2835-8. https://doi.org/10.7314/APJCP.2013.14.5.2835
- Cox ME, Gleave ME, Zakikhani M, et al (2009). Insulin receptor expression by human prostate cancers. Prostate, 69, 33-40. https://doi.org/10.1002/pros.20852
- De Loureiro JA, Janz GJ (1944). Iodometric and colorimetric methods for the estimation of calcium in serum based on the use of an improved permanganate solution. Biochem J, 38, 16-9.
- Ding J, Tang J, Chen X, et al (2013). Expression characteristics of proteins of the insulin-like growth factor axis in non-small cell lung cancer patients with preexisting type 2 diabetes mellitus. Asian Pac J Cancer Prev, 14, 5675-80. https://doi.org/10.7314/APJCP.2013.14.10.5675
- Esposito K, Chiodini P, Capuano A, et al (2013). Effect of metabolic syndrome and its components on prostate cancer risk: meta-analysis. J Endocrinol Invest, 36, 132-9. https://doi.org/10.1007/BF03346748
- Haas GP, Sakr WA (1997). Epidemiology of prostate cancer. CA Cancer J Clin, 47, 273-87. https://doi.org/10.3322/canjclin.47.5.273
- Kahn CR, Rosenthal AS (1979). Immunologic reactions to insulin, insulin allergy, insulin resistance and autoimmune insulin syndrome. Diabetes Care, 2, 283-95. https://doi.org/10.2337/diacare.2.3.283
- Morss AS, Edelman ER (2007). Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J Biol Chem, 282, 14635-44. https://doi.org/10.1074/jbc.M608565200
- Pollak M (2012). The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer, 12, 159-69.
- Richardson LC, Pollack LA (2005). Therapy insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol, 2, 48-53. https://doi.org/10.1038/ncponc0062
- Trinder P (1969). Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem, 6, 24-7. https://doi.org/10.1177/000456326900600108
- Trinder P (1969). Determination of serum cholesterol by enzymatic colorimetric method. Ann Clin Biochem, 6, 24-7. https://doi.org/10.1177/000456326900600108
- Xiang YZ, Xiong H, Cui ZL, et al (2013). The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence. J Exp Clin Cancer Res, 32, 9. https://doi.org/10.1186/1756-9966-32-9
- Xiong ZP, Huang F, Lu MH, et al (2012). Association between insulin-like growth factor-2 expression and prognosis after transcatheterarterial chemoembolization and octreotide in patients with hepatocellular carcinoma. Asian Pac J Cancer Prev, 13, 3191-4. https://doi.org/10.7314/APJCP.2012.13.7.3191
- Zhang YR, Xu Y, Yang K, et al (2012). Association of six susceptibility loci with prostate cancer in northern Chinese men. Asian Pac J Cancer Prev, 13, 6273-6. https://doi.org/10.7314/APJCP.2012.13.12.6273
Cited by
- The Metabolic Syndrome is Associated with More Aggressive Prostate Cancer vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.4029
- Malignant Neoplasm Burden in Nepal - Data from the Seven Major Cancer Service Hospitals for 2012 vol.16, pp.18, 2016, https://doi.org/10.7314/APJCP.2015.16.18.8659
- Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer vol.118, pp.9, 2018, https://doi.org/10.1038/s41416-018-0055-4
- Serum C-peptide concentration and prostate cancer vol.97, pp.31, 2018, https://doi.org/10.1097/MD.0000000000011771
- Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise vol.19, pp.7, 2018, https://doi.org/10.1111/obr.12674
- Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer pp.1476-5608, 2019, https://doi.org/10.1038/s41391-018-0123-0